Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Pediatric Cancer: early-phase trial registry
31 of 52 indexed Pediatric Cancer trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #271 of 28,707 conditions by registered trial count.
52 US clinical trials · 31 currently recruiting · #271 of 28,707 conditions by registered trial count
Pediatric Cancer: 52 US clinical trials tracked, 31 recruiting.
Pediatric Cancer is the subject of 52 registered US clinical trials on ClinicalTrials.gov, 31 of them currently open to new participants. 1 are in Phase 3-4 (later-stage) and 9 in Phase 1-2 (earlier-stage). The most active sponsor is Children's Hospital of Philadelphia, running 5 of these trials.
Enrollment posture brief
Registry condition pediatric-cancer
OPEN 31 | RECR 60% | LATE 1 | EARLY 9 | RANK #271 | SPON 5
Volume-matched condition peers
Nearest open-share peer: Nutrition, Healthy (59% recruiting · 32 trials)
Pediatric Cancer lists 31 open slots (60% of 52 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Pediatric Cancer on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Pediatric Cancer is recruiting above its size-band peers.
31 of 52 indexed trials (59.6%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Pediatric Cancer trials is spread across many organizations.
Children's Hospital of Philadelphia accounts for 5 of 52 trials (9.6%). 35 distinct sponsors appear on at least one study for this condition label.
-
Most Pediatric Cancer trials plan to enrol fewer than 100 people.
Median target enrolment is 60 among the 52 trials that report a genuine target (sentinel values excluded). 33 of those (63.5%) plan for fewer than 100 participants.
-
Pediatric Cancer splits between interventional and observational designs.
32 interventional and 20 observational studies make up this index (61.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
52 total, page 1 of 2
LIFE Cancer Survivorship Database for Pediatric Cancer
Children's Hospital Los Angeles
NCT01518400
Psychological Benefits of a Normalized Camping Experience for Children With Cancer
National Cancer Institute (NCI)
NCT00001186
Childhood Cancer Predisposition Study (CCPS)
Emory University
NCT04511806
Beat Childhood Cancer Specimen Banking and Data Registry
Giselle Sholler
NCT04715178
UNC Childhood, Adolescent, and Young Adult Cancer Cohort
UNC Lineberger Comprehensive Cancer Center
NCT05096923
Multisite Implementation of COMPRENDO
University of California, San Diego
NCT06055296
Risk Factors, Clinical Characteristics and Outcomes of Acute Infection With Coronavirus 2019 (COVID-19) In Children
St. Jude Children's Research Hospital
NCT04371315
Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer
Nemours Children's Clinic
NCT05294302
Feasibility and Acceptability of Internet-based Parent-child Interaction Therapy (I-PCIT) in Pediatric Cancer
Johns Hopkins All Children's Hospital
NCT06346782
Ovarian Tissue Cryopreservation in Post Pubertal (OTC-Post Pubertal)
Erin Rowell
NCT05309746
Development and Evaluation of a Screening Approach for Sexual Dysfunction in AYA Patients With and Surviving Childhood Cancer
University of Colorado, Denver
NCT05524610
Cardiotoxicity Assessment Through Comprehensive Heart Imaging to Predict Heart Failure
Hari Narayan
NCT04262830
Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells
Ann & Robert H Lurie Children's Hospital of Chicago
NCT05120518
Response to Influenza Vaccination in Pediatric Oncology Patients
St. Jude Children's Research Hospital
NCT05384288
Massage Impact on Sleep in Pediatric Oncology
Children's Hospital of Philadelphia
NCT06892158
Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients
St. Jude Children's Research Hospital
NCT05468359
Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients
Wake Forest University Health Sciences
NCT04948619
Lurbinectedin in FET-Fused Tumors
Children's Hospital of Philadelphia
NCT05918640
Improving Communication Between AYA Oncology Patients and Clinicians: A Patient-Centered Intervention
Connecticut Children's Medical Center
NCT06982066
LCI-PED-NOS-EXER-001: Exercise in Pediatric Oncology Patients
Wake Forest University Health Sciences
NCT05058508
Feasibility/Acceptability of Attentional-Control Training in Survivors
Children's National Research Institute
NCT05528939
Biomarkers of Resiliency In Childhood Cancer Surgery
Mayo Clinic
NCT06674811
Cancer Care Companion
Washington University School of Medicine
NCT07278778
PediRISE Feasibility
Dana-Farber Cancer Institute
NCT06283251
Generating Novel Translational and Therapeutic Strategies Based on a Multicenter, Pediatric and AYA Evolutionary Tumor Board (pedsETB)
H. Lee Moffitt Cancer Center and Research Institute
NCT06423950
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Children's Hospital of Philadelphia
NCT05024929
Medically Tailored Meals for Kids
UNC Lineberger Comprehensive Cancer Center
NCT06814795
Digital Art Therapy for Young Cancer Survivors
UNC Lineberger Comprehensive Cancer Center
NCT06789666
Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Children's Hospital of Philadelphia
NCT06458036
Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Children's Hospital of Philadelphia
NCT05783323
Shareholder-driven Co-design and Piloting of Spanish Educational Videos About High Yield Pediatric Oncology Topics
University of Colorado, Denver
NCT07288476
Enrollment on the Childhood Cancer Research Network (CCRN) of the Children's Oncology Group
Children's Oncology Group
NCT01117168
Genetic Overlap Between Anomalies and Cancer in Kids in the Children's Oncology Group: The COG GOBACK Study
Children's Oncology Group
NCT05071859
Estimating Setup Uncertainty in Pediatric Proton Therapy Using Volumetric Images
St. Jude Children's Research Hospital
NCT04125095
Feasibility Usability & Acceptability Study: Symptom Reporting by Children Adolescents & Young Adults w/Cancer
Stanford University
NCT06824441
Barriers and Facilitators in Access to OT/PT in Pediatric Cancer Survivors
M.D. Anderson Cancer Center
NCT05305950
Durvalumab and Tremelimumab for Pediatric Malignancies
AstraZeneca
NCT03837899
Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma
University of California, San Francisco
NCT03739372
Understanding the Late Effects of Surviving a Pediatric Brain Tumor
Memorial Sloan Kettering Cancer Center
NCT03208387
ATOMIC Mobile App to Increase Physical Activity (PA) Levels in Survivors of Childhood Cancer
Connecticut Children's Medical Center
NCT05792566
A Study of N9 Chemotherapy in Children With Neuroblastoma
Memorial Sloan Kettering Cancer Center
NCT04947501
Implementation of Family Psychosocial Risk Assessment in Pediatric Cancer
Nemours Children's Clinic
NCT04446728
Feasibility Neurocognitive Outcome After Transplant
Stanford University
NCT02300961
An English/Spanish Mobile Augmented Reality Pain Assessment App for Hispanic/Latino Pediatric Cancer Patients
ALTality
NCT06635434
Symptom Screening Linked to Care Pathways
The Hospital for Sick Children
NCT04614662
Red Blood Cell - IMProving trAnsfusions for Chronically Transfused Recipients
Westat
NCT05255445
Translating ECHOS2 Into an mHealth Platform
Washington University School of Medicine
NCT05923242
A Randomized Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT
Phoenix Children's Hospital
NCT03176849
Intervention Development and Evaluation to Reduce Disparities in Quality of Life for Latino Families Impacted by Cancer
University of California, Irvine
NCT06622252
Expressive Storytelling to Share Adolescents/Young Adults Cancer Stories
Vanderbilt University
NCT04855487
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 3 |
| Phase 4 | 1 |
Top Sponsors
Named interventions
Most-linked intervention names on Pediatric Cancer records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Pediatric Cancer trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Pediatric Cancer page
52 registered trials, 31 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 31 Pediatric Cancer trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Children's Hospital of Philadelphia sponsors the most Pediatric Cancer trials on record, review their full trial history before evaluating a specific study. See Children's Hospital of Philadelphia's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Pediatric Cancer condition card totals 52 registered trials; most-linked intervention Cyclophosphamide; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.